[1]
|
K. Chanin, F. Vallejo-Manzur, G. L. Sternbach, et al., “Pulmonary Manifestations of Rheumatoid Arthritis,” Hospital Physician, 2001, pp. 23-28.
|
[2]
|
C. Turesson and L. T. Jacobsson, “Epidemiology of Extra-Articular Manifestations in Rheumatoid Arthritis,” Scandinavian Journal of Rheumatology, Vol. 33, No. 2, 2004, pp. 65-72. doi:10.1080/03009740310004621
|
[3]
|
C. Turesson, L. Jacobsson and U. Bergstrom, “Extra-Articular Rheumatoid Arthritis: Prevalence and Mortality,” Rheumatology (Oxford), Vol. 38, No. 7, 1999, pp. 668-674. doi:10.1093/rheumatology/38.7.668
|
[4]
|
B. R. Gochuico, N. A. Avila, C. K. Chow, L. J. Novero, H. P. Wu, P. Ren, S. D. MacDonald, W. D. Travis, M. P. Stylianou and I. O. Rosas, “Progressive Preclinical Interstitial Lung Disease in Rheumatoid Arthritis,” Archives of Internal Medicine, Vol. 168, No. 2, 2008, pp. 159-166.
doi:10.1001/archinternmed.2007.59
|
[5]
|
V. Saravanan and C. A. Kelly, “Reducing the Risk of Methotrexate Pneumonitis in Rheumatoid Arthritis,” Rheumatology (Oxford), Vol. 43, No. 2, 2004, pp. 143-147.
doi:10.1093/rheumatology/keg466
|
[6]
|
C. Kelly and V. Saravanan, “Treatment Strategies for a Rheumatoid Arthritis Patient with Interstitial Lung Disease,” Expert Opinion on Pharmacotherapy, Vol. 9, No. 18, 2008, pp. 3221-3230.
doi:10.1517/14656560802591430
|
[7]
|
F. C. Arnett, S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, T. A. Medsger and R. L. Hunder, “The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis,” Arthritis Rheum, Vol. 31, No. 3, 1988, pp. 315-324. doi:10.1002/art.1780310302
|
[8]
|
C. LeMaistre, “A Statement by the Committee on Standards for Epidemiology Surveys on Chronic Respiratory Disease of the American Thoracic Society,” National Tuberculosis and Respiratory Disease Association, New York, 1969, p. 32.
|
[9]
|
“Recommended Respiratory Disease Questionnaires for Use with Adults and Children in Epidemiological Research,” 1978, pp. 7-53.
http://www.thoracic.org/statements/resources/archive/rrdquacer.pdf
|
[10]
|
E. Akhtar, S. Bilal, et al., “Prevelence of Arthritis in India and Pakistan: A Review,” Rheumatology International, Vol. 31, No. 7, 2011, pp. 849-855.
doi:10.1007/s00296-011-1820-3
|
[11]
|
A. N. Malviya, S. K. Kapoor, et al., “Prevelence of Rheumatoid Arthritis in the Adult Indian Population,” Rheumatology International, Vol. 13, No. 4, 1993, pp. 13-14.
|
[12]
|
P. Milind and K. Sushila, “How to Live with Rheumatoid Arthritis,” International Research Journal of Pharmacy, Vol. 3, No. 3, 2012, pp. 115-121.
|
[13]
|
L. M. Pamell, C. L. Galligon and C. N. Fish, “Sex Affects Immunity Autoimmune,” 2012.
|
[14]
|
F. R Lake, “Interstitial Lung Disease in Rheumatoid Ar tritis,” 2012, pp. 1-4.
http://www.uptodate.com/contents/interstitial-lung-disease-in-rheumatoid-arthritis
|
[15]
|
R. L. Collin, R. A. Turner, A. M. Johnson, et al., “Obstructive Pulmonary Disease in Rheumatoid Arthritis,” Arthritis Rheum, Vol. 19, No. 3, 1976, pp. 623-628.
doi:10.1002/art.1780190316
|
[16]
|
E. Gabbay, R. Tarala, R. Will, et al., “Interstitial Lung Disease in Recent Onset Rheumatoid Arthritis,” American Journal of Respiratory and Critical Care Medicine, Vol. 156, No. 2, 1997, pp. 528-535.
doi:10.1164/ajrccm.156.2.9609016
|
[17]
|
J. K. Dawson, H. E. Fewins, J. Desmond, et al., “Fibrosing Alveolitis in Patient with Rheumatoid Arthritis as Assessed by High Resolution Computed Tomography, Chest Radiography and Pulmonary Function Tests,” Thorax, Vol. 56, No. 8, 2001, pp. 622-627.
doi:10.1136/thorax.56.8.622
|
[18]
|
E. J. Hall and D. J. Brenner, “Cancer Risks from Diagnostic Radiology,” British Journal of Radiology, Vol. 81, No. 965, 2008, pp. 362-378. doi:10.1259/bjr/01948454
|
[19]
|
J. W. Card, W. J. Racz, J. F. Brien, S. B. Margolin and T. E. Massey, “Differential Effects of Pirfenidone on Acute Pulmonary Injury and Ensuing Fibrosis in the Hamster Model of Amiodarone-Induced Pulmonary Toxicity,” Toxicological Sciences, Vol. 75, No. 1, 2003, pp. 169-180.
doi:10.1093/toxsci/kfg167
|
[20]
|
W. A. Gahl, M. Brantly, J. Troendle, N. A. Avila, A. Padua, C. Montalvo, H. Cardona, K. A. Calis and B. Gochuico, “Effect of Pirfenidone on the Pulmonary Fibrosis of Hermansky-Pudlaksyndrome,” Molecular Genetics and Metabolism, Vol. 76, No. 3, 2002, pp. 234-242.
doi:10.1016/S1096-7192(02)00044-6
|